Americans Have not Been Truthful about Following COVID-19 Precautions
More than 4 in 10 US adults have either misrepresented their COVID-19 status or failed to adhere to public health measures. A new survey found out why.
ADA/EASD Consensus Report on T2D Management: Coauthor Talks Take-homes for Primary Care
Nisa Maruthur, MD, MHS, a primary care physician and consensus report coauthor, discusses elements of the most effective care for patients with type 2 diabetes (T2D).
Simple Primary Care Screening Tool Predicts Asthma Diagnosis in Preschoolers
The noninvasive, easily administered tool was able to predict at age 3 years children who would be diagnosed with asthma at age 5 years.
Clinical Practice Guidelines Could be More Primary Care-friendly, says Nisa Maruthur, MD, MHS
Dr Maruthur, a PCP and coauthor for the new ADA/EASD consensus report on T2D, says that's why this report includes the "tips on implementation" sections.
ADA/EASD Calls for Wide Systemic Change to Address Impact of Social Determinants of Health
As long as the role of social determinants of health in T2D is not prioritized, care for these patients will remain poor and outcomes will not improve, says consensus report author.
SGLT-2 Inhibitors, GLP-1 Receptor Agonists not Cost-effective as First-Line T2D Therapy
When modeled as first-line therapy vs metformin, treatment benefit was significantly outweighed by cost for both classes.
Primary Care Would Benefit from Education on Use of SGLT-2 Inhibitors, GLP-1 Mimetics: Nisa Maruthur, MD, MHS
Dr Maruthur, a primary care physician, helped develop the new ADA/EASD consensus report on T2D management and has suggestions.
Younger Age at Type 2 Diabetes Diagnosis in Adults Increases Risk for Poor Outcomes
A T2D diagnosis in adults aged 50 to 59 years vs 60 to 69 years or ≥70 years was linked to significantly increased risk for cardio- and cerebrovascular disease and all-cause mortality.
ADA, EASD 2022 Consensus Report from the Primary Care Point of View, with Nisa Maruthur, MD, MHS
Dr Maruthur, of Johns Hopkins Medicine, talks about how the concept of "holistic" patient care continues to expand in the management of persons with T2D.
Current Telehealth Use 88% More Likely by Patients with Chronic Conditions: Survey
Telehealth continues to support continuity of care and to increase access to and willingness to use the health care system, according to survey authors.
Antivirals Recommended for Influenza Treatment & Chemoprophylaxis: Basics, Notes, Cautions
This influenza antiviral brush-up slide show reminds you of key features of the 4 FDA-recommended medications, at-a-glance.
FDA Recall Announced for Atenolol, Clopidogrel based on Labeling Mix-up
Only 1 lot of each medication was affected by the mislabeling, according to generic repackaging and distribution services company Golden State Medical Supply.
Early Natural Menopause is a Risk Factor for Lung Disease, Mortality in Women who Smoke
After early natural (vs surgical) menopause, women who continued to smoke had 4.5-fold greater risk of lung cancer and related mortality, report study authors.
Dementia Risk May be Driven by Multimorbidity vs Single Risk Factors, Suggests a New Study
Multimorbidity was associated with a 63% increased risk for dementia among adults older than age 60 years followed for up to 15 years.
Causes of Secondary Hypertension: A Guideline Topline for Primary Care
Obstructive sleep apnea is a cause of secondary hypertension in up to 50% of cases; more common causes here, from the 2017 ACC/AHA hypertension guidelines.
SGLT2 Inhibitors May be "Optimal" Treatment for HFpEF, HFmrEF, a New Meta-analysis Suggests
SGLT-2 inhibitors and drugs to treat HFrEF were compared for efficacy in patients with HF with LVEF ≥40%.
ADA, EASD Release Update on Management of Hyperglycemia in Type 2 Diabetes
The new consensus recommends holistic, person centered care focused on glycemic and weight management, CV risk reduction, and cardiorenal organ protection.
T2D Patient Preference Survey Finds Low Side Effect Profile Outranks CVD Protection for Newer OADs
New survey findings suggest the need for more in-depth conversations with patients about benefits and harms of newer oral therapies for type 2 diabetes.
FreeStyle Libre 3 CGM Linked with Reduced Hospital Admissions in Patients with T2D
Hospital admissions among patients with T2D taking basal insulin only were reduced by 67% one year after beginning treatment with the CGM system.
Migraine with Aura Characterized as Independent Risk Factor for Atrial Fibrillation
Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.
Patient Wait Time for a Family Practice Appointment: 15 Major US Cities Surveyed
Average patient wait time for a nonemergent appointment with an FP decreased between 2017 and 2020, according to a Merritt Hawkins survey. Is that a good sign?
Hypertension-related CVD Most Common ED Presentation in the US
Approximately one-third of CV-related ED visits are for hypertension-related conditions, including 13% for essential hypertension among women.
Intervention Reduces Aspirin Use in Patients with AF, VTE Taking Warfarin, Improves Outcomes
An aspirin deprescribing intervention at anticoagulation clinics led to a 50% reduction in use among patients with AF, VTE prescribed warfarin.
Semaglutide 2.4 mg: Weight Loss in Real-world Study Matches STEP Trial Program Findings
Semaglutide prescribed in clinical practice helped more than half of study participants achieve weight loss of ≥10% at 6 months.
"Long COVID is Not Anxiety," but that Was an Early Hypothesis
Long COVID is now recognized as real, in the medical community and in Washington, DC, but 2 years ago it was a different story, says AAPM&R's Steven Flanagan, MD.
Tirzepatide Reduces Time to HbA1c Targets by Up to 3 Months vs Semaglutide, Insulin Degludec
Tirzepatide in an exploratory analysis of SURPASS-2 and -3 trials added proof of shorter time to glycemic targets and weight loss goals to superior reduction of HbA1c.
The Brunt of the Long COVID Patient Burden May Fall on Primary Care, says Rehabilitation Medicine Expert
NYU Langone Rusk Rehabilitation medical director Steven Flanagan, MD, discusses the "second crisis" of the pandemic and the impact on primary care.
COPD: Pulmonary Rehab is Effective Regardless of Inhaled Triple Therapy Use
In-hospital pulmonary rehabilitation improves function and symptoms in COPD patients whether they are on triple therapy or not, a new study confirms.
Finerenone: FDA Expands Label to Include Cardiovascular Outcomes Trial Data
Data from the pivotal phase 3 FIGARO-DKD cardiovascular outcomes trial with finerenone reaffirms the agent's dual cardiorenal risk reduction benefits in T2D-associated CKD.
Long COVID Presents Many More Questions than Answers, says AAPM&R President-elect Flanagan
Long COVID symptoms are reported by persons who have had only mild disease, who have been vaccinated and boosted, and even those who had asymptomatic infection.
